About CJC-1295 (No DAC)
CJC-1295 (No DAC) is a short-acting GHRH analogue that supports the natural signaling pathways involved in growth hormone release. Its shorter activity window allows for more controlled and pulsatile interaction with the body's endocrine system.
About Ipamorelin
Ipamorelin is a selective ghrelin receptor modulator that complements natural GH signaling. It is designed to work in harmony with the body's regulatory mechanisms without significantly influencing other hormonal pathways.
Synergistic formulation
When combined, CJC-1295 (No DAC) and Ipamorelin create a complementary profile that supports natural rhythms of growth hormone activity. This blend is commonly explored in protocols focused on performance optimization, recovery support, and overall physiological balance.
General areas of interest
This formulation is being explored in relation to:
Maintenance of lean body composition
Support for recovery processes
Sleep quality optimization
General vitality and physical performance
Healthy aging support pathways
Usage approach
Usage may vary depending on individual preferences and protocols. A commonly used range is 10–14 units per day, typically divided into two applications.
The dosing mechanism allows precise adjustment via a rotating dial, with each unit corresponding to a defined increment.
Application is typically performed in areas such as the abdominal region or upper leg, with rotation of application sites recommended.
Product format
1 pen = 200 units
Each unit contains:
25 mcg CJC-1295 (No DAC)
50 mcg Ipamorelin
Estimated duration per pen: approximately 20 days, depending on usage.
Reference values
1 unit = 25 mcg / 50 mcg
5 units = 125 mcg / 250 mcg
7 units = 175 mcg / 350 mcg
10 units = 250 mcg / 500 mcg
Disclaimer: — This product is intended for research and educational purposes only. It is not intended to diagnose, treat, cure, or prevent any disease.